Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01256749 · ClinicalTrials.gov registry record

A Comparative Study of Global 12 Lead Electroencephalogram to Frontal SedlineTM Electroencephalogram

A clinical trial of Craniotomy and Transphenoidal Pituitary Resection, sponsored by Loma Linda University.

Completed
Registry status
31
Enrollment target
1
Study location

NCT01256749 is a study of Craniotomy and Transphenoidal Pituitary Resection that has completed, run by Loma Linda University. The registered enrollment target is 31 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01256749, a study of Craniotomy and Transphenoidal Pituitary Resection, has completed, sponsored by Loma Linda University.

COMPLETED
Registry status
31 participants
Enrollment target
1
Study location

Study Summary

The fundamental reason for comparing the ability of the Frontal Sedline TM Electroencephalogram (PSA EEG) to standard Global 12 Lead Electroencephalogram (EEG) for burst suppression detection is to determine if a less expensive, less invasive and possibly more convenient bifrontal EEG monitor can be effective for evaluation of anesthesia-induced intraoperative burst suppression therapy (IBST) for cerebral protection.

Study Locations (1)

California

  • Loma Linda University - Loma Linda

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2010-12
Est. Completion 2013-11

Sponsor

Loma Linda University

237 total trials

What the Registry Record Tells You About NCT01256749

The ClinicalTrials.gov registry entry for NCT01256749 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Craniotomy appearing as the primary indexed condition, and to 0 interventions.

NCT01256749 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01256749 about?

NCT01256749 is a clinical study titled "A Comparative Study of Global 12 Lead Electroencephalogram to Frontal SedlineTM Electroencephalogram". The fundamental reason for comparing the ability of the Frontal Sedline TM Electroencephalogram (PSA EEG) to standard Global 12 Lead Electroencephalogram (EEG) for burst suppression detection is to determine if a less expensive, less invasive and possibly more convenient bifrontal EEG monitor can be...

What is the current status of trial NCT01256749?

This trial is currently completed. The enrollment target is 31 participants. The study started on 2010-12. Estimated completion is 2013-11.

What conditions does trial NCT01256749 study?

This clinical trial studies the following conditions: Craniotomy, Transphenoidal Pituitary Resection.

Who is sponsoring clinical trial NCT01256749?

This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01256749 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Craniotomy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.